Orion To Release H1 2024 Report And Host Webcast On August 8
25 Jul 2024 //
GLOBENEWSWIRE
Merck & Co. opts in on Orion`s hormone-dependent cancer candidates
01 Jul 2024 //
FIERCE BIOTECH
Proteros and Orion Pharma agree on a long-term multi-target collaboration
06 Sep 2023 //
GLOBENEWSWIRE
Orion Group Financial Statement documents 2022
28 Feb 2023 //
GLOBENEWSWIRE
Orion’s collaboration partner Bayer submits application for of darolutamide
21 Apr 2022 //
GLOBENEWSWIRE
ARASENS Phase III trial for prostate cancer treatment meets primary endpoint
03 Dec 2021 //
PHARMAFILE